Kunal Patel, MD
Pulmonary Disease · Pleasant Prairie, WINPI 1548600240
Payments from drug & device makers
What this record shows
This record is dominated by education: $6,050 of the $8,699 with a category attached, or 69.5%. Intuitive Surgical accounts for 69.5% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2022 at $3,704 and has fallen 79.4% since, to $761 in 2025.
Across 107 payments — averaging $81.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$6K
- Sanofi$797
- Regeneron Healthcare Solutions, Inc.$402
- Grifols USA, LLC$189
- Novartis$174
- Boehringer Ingelheim$167
- plus $926 from 17 others
What the payments were for
- Food & beverage$2,64930%
- Education$6,05070%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 3 | $6,044 |
| Sanofi | 28 | $797 |
| Regeneron Healthcare Solutions, Inc. | 12 | $402 |
| Grifols USA, LLC | 7 | $189 |
| Novartis | 5 | $174 |
| Boehringer Ingelheim | 7 | $167 |
| AstraZeneca | 8 | $152 |
| GSK | 8 | $152 |
| Philips North America LLC | 7 | $136 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $58 |
| Insmed, Inc. | 3 | $58 |
| Electromed, Inc. | 4 | $57 |
| Viatris Specialty LLC | 2 | $54 |
| Abiomed | 1 | $50 |
| Amgen | 2 | $39 |
| Mallinckrodt Hospital Products Inc. | 1 | $29 |
| Verona Pharma, Inc. | 1 | $25 |
| Pulmonx Corporation | 1 | $22 |
| Genentech USA, Inc. | 1 | $21 |
| Baxter Healthcare | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Johnson & Johnson | 1 | $18 |
| Medical Graphics Corporation | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ION$3,000
- Da Vinci Surgical System$3,000
- DUPIXENT$120
How this compares
$8,699 in reported general payments places this provider in the 85th percentile of 247 pulmonary disease providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 21 | $89,843 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 117 | $80,991 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 40 | $19,680 |
| Breo ElliptaFluticasone/Vilanterol | 33 | $16,234 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 20 | $12,483 |
| Incruse ElliptaUmeclidinium Bromide | 26 | $9,320 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 11 | $7,318 |
| DuleraMometasone/Formoterol | 12 | $4,228 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 116 | $3,359 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 21 | $2,823 |
| Bupropion Hcl SrBupropion Hcl | 22 | $518 |
| Montelukast Sodium | 44 | $420 |
| Azelastine Hcl | 15 | $413 |
| Azithromycin | 26 | $236 |
| Prednisone | 70 | $213 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Incruse Ellipta | $152 | $126,226216 claims |
| AstraZenecaBreztri Aerosphere | $152 | $12,48320 claims |
| Boehringer IngelheimStiolto Respimat | $167 | $7,31811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 247 pulmonary disease providers in Wisconsin.
Other pulmonary disease in Pleasant Prairie
- Srikanth DavuluriPleasant Prairie$20K
- Tricia GriffithsPleasant Prairie$12K
- Jonathan KurmanMilwaukee$803K
- Mouhammed RihawiMilwaukee$713K
- Hasnain BawaadamKenosha$686K
- Alfred HabelKenosha$194K
- Manar Al ShahrouriGreen Bay$61K
- Kurt HuMilwaukee$55K
- Julie BillerMilwaukee$52K
- Mark BarashMilwaukee$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.